|
1
|
Vrdoljak E, Wojtukiewicz MZ, Pienkowski T,
Bodoky G, Berzinec P, Finek J, Todorović V, Borojević N and
Croitoru A; South eastern European Research Oncology Group, :
Cancer epidemiology in central, south and eastern European
countries. Croat Med J. 52:478–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gann PH: Risk factors for prostate cancer.
Rev Urol. 4 (Suppl 5):S3–S10. 2002.PubMed/NCBI
|
|
3
|
Carruba G: Estrogens and mechanisms of
prostate cancer progression. Ann NY Acad Sci. 1089:201–217. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rohrmann S, Platz EA, Selvin E, Shiels MS,
Joshu CE, Menke A, Feinleib M, Basaria S, Rifai N, Dobs AS, et al:
The prevalence of low sex steroid hormone concentrations in men in
the third national health and nutrition examination survey (NHANES
III). Clin Endocrinol (Oxf). 75:232–239. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonkhoff H: Estrogen receptor signaling in
prostate cancer: Implications for carcinogenesis and tumor
progression. Prostate. 78:2–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yao S, Till C, Kristal AR, Goodman PJ,
Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L,
et al: Serum estrogen levels and prostate cancer risk in the
prostate cancer prevention trial: A nested case-control study.
Cancer Causes Control. 22:1121–1131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsai CJ, Cohn BA, Cirillo PM, Feldman D,
Stanczyk FZ and Whittemore AS: Sex steroid hormones in young
manhood and the risk of subsequent prostate cancer: A longitudinal
study in African-Americans and caucasians (United States). Cancer
Causes Control. 17:1237–1244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barba M, Yang L, Schünemann HJ, Sperati F,
Grioni S, Stranges S, Westerlind KC, Blandino G, Gallucci M, Lauria
R, et al: Urinary estrogen metabolites and prostate cancer: A
case-control study and meta-analysis. J Exp Clin Cancer Res.
28:1352009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parker MG: Structure and function of
estrogen receptors. Vitam Horm. 51:267–287. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Levin ER and Hammes SR: Nuclear receptors
outside the nucleus: Extranuclear signaling by steroid receptors.
Nat Rev Mol Cell Biol. 17:783–797. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonkhoff H and Berges R: The evolving role
of oestrogens and their receptors in the development and
progression of prostate cancer. Eur Urol. 55:533–542. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng J, Lee EJ, Madison LD and Lazennec
G: Expression of estrogen receptor beta in prostate carcinoma cells
inhibits invasion and proliferation and triggers apoptosis. FEBS
Lett. 566:169–72. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ellem SJ and Risbridger GP: The dual,
opposing roles of estrogen in the prostate. Ann NY Acad Sci.
1155:174–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Omoto Y and Iwase H: Clinical significance
of estrogen receptor β in breast and prostate cancer from
biological aspects. Cancer Sci. 106:337–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Enmark E, Pelto-Huikko M, Grandien K,
Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M and
Gustafsson JA: Human estrogen receptor beta-gene structure,
chromosomal localization, and expression pattern. J Clin Endocrinol
Metab. 82:4258–4265. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Christoforou P, Christopoulos PF and
Koutsilieris M: The role of estrogen receptor β in prostate cancer.
Mol Med. 20:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao
Y, McNeal JE and Ho SM: Dynamic regulation of estrogen
receptor-beta expression by DNA methylation during prostate cancer
development and metastasis. Am J Pathol. 164:2003–2012. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rosenkranz K, Hinney A, Ziegler A, Hermann
H, Fichter M, Mayer H, Siegfried W, Young JK, Remschmidt H and
Hebebrand J: Systematic mutation screening of the estrogen receptor
beta gene in probands of different weight extremes: Identification
of several genetic variants. J Clin Endocrinol Metab. 12:4524–4527.
1998. View Article : Google Scholar
|
|
19
|
Fu C, Dong WQ, Wang A and Qiu G: The
influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on
prostate cancer risk. Tumour Biol. 35:8319–8328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Putnik M, Zhao C, Gustafsson JA and
Dahlman-Wright K: Effects of two common polymorphisms in the
3′untranslated regions of estrogen receptor beta on mRNA stability
and translatability. BMC Genet. 10:552009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrett LW, Fletcher S and Wilton SD:
Regulation of eukaryotic gene expression by the untranslated gene
regions and other non-coding elements. Cell Mol Life Sci.
69:3613–2634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu KD, Rao NY, Chen AX, Fan L, Yang C and
Shao ZM: A systematic review of the relationship between
polymorphic sites in the estrogen receptor-beta (ESR2) gene and
breast cancer risk. Breast Cancer Res Treat. 126:37–45. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rezende LM, Marson FA, Lima CS and
Bertuzzo CS: Variants of estrogen receptor alpha and beta genes
modify the severity of sporadic breast cancer. Gene. 608:73–78.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu X, Yamano Y, Takahashi H, Koda M,
Fujiwara Y, Hisada A, Miyazaki W and Katoh T: Associations between
estrogen receptor genetic polymorphisms, smoking status, and
prostate cancer risk: A case-control study in Japanese men. Environ
Health Prev Med. 20:332–337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Yang X, Zhang R, Zhang D, Li B,
Zhang D, Li Q and Xiong Y: No association between estrogen
receptor-Β Rs4986938 and cancer risk: A systematic review and
meta-analysis. Iran J Public Health. 48:784–795. 2019.PubMed/NCBI
|
|
26
|
Bharathi C, Anupama D, Pratibha N and
Venkateshwari A: Impact of genetic variants in estrogen receptor-β
gene in the etiology of uterine leiomyomas. J Reprod Infertil.
20:151–160. 2019.PubMed/NCBI
|
|
27
|
Lattrich C, Häring J, Schüler S,
Skrzypczak M, Ortmann O and Treeck O: Polymorphisms in the promoter
region of estrogen receptor β gene in endometrial cancer. Arch
Gynecol Obstet. 289:631–635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schüler S, Lattrich C, Skrzypczak M, Fehm
T, Ortmann O and Treeck O: Polymorphisms in the promoter region of
ESR2 gene and susceptibility to ovarian cancer. Gene. 546:283–287.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai Z, Tian T, Wang M, Yang T, Li H, Lin
S, Hao Q, Xu P, Deng Y, Zhou L, et al: Genetic polymorphisms of
estrogen receptor genes are associated with breast cancer
susceptibility in Chinese women. Cancer Cell Int. 19:112019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye S, Dhillon S, Ke X, Collins AR and Day
IN: An efficient procedure for genotyping single nucleotide
polymorphisms. Nucleic Acids Res. 29:E88. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Horvath LG, Henshall SM, Lee CS, Head DR,
Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G,
et al: Frequent loss of estrogen receptor-beta expression in
prostate cancer. Cancer Res. 61:5331–5335. 2001.PubMed/NCBI
|
|
33
|
Gabal SM, Habib FM, Helmy DO and Ibrahim
MF: Expression of estrogen receptor-B (ER-B) in benign and
malignant prostatic epithelial cells and its correlation with the
clinico-pathological features. J Egypt Natl Canc Inst. 19:239–248.
2007.PubMed/NCBI
|
|
34
|
Latil A, Bieche I, Vidaud D, Lidereau R,
Berthon P, Cussenot O and Vidaud M: Evaluation of androgen,
estrogen (ER alpha and ER beta), progesterone receptor expression
inhuman prostate cancer by real-time quantitative reverse
transcription-polymerase chain reaction assays. Cancer Res.
61:1919–1926. 2001.PubMed/NCBI
|
|
35
|
Pasquali D, Staibano S, Prezioso D, Franco
R, Esposito D, Notaro A, De Rosa G, Bellastella A and Sinisi AA:
Estrogen receptor beta expression in human prostate tissue. Mol
Cell Endocrinol. 178:47–50. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Leung YK, Lam HM, Wu S, Song D, Levin L,
Cheng L, Wu CL and Ho SM: Estrogen receptor beta2 and beta5 are
associated with poor prognosis in prostate cancer, and promote
cancer cell migration and invasion. Endocr Relat Cancer.
17:675–689. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zellweger T, Stürm S, Rey S, Zlobec I,
Gsponer JR, Rentsch CA, Terracciano LM, Bachmann A, Bubendorf L and
Ruiz C: Estrogen receptor β expression and androgen receptor
phosphorylation correlate with a poor clinical outcome in
hormone-naive prostate cancer and are elevated in
castration-resistant disease. Endocr Relat Cancer. 20:403–413.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grindstad T, Skjefstad K, Andersen S, Ness
N, Nordby Y, Al-Saad S, Fismen S, Donnem T, Khanehkenari MR, Busund
LT, et al: Estrogen receptors α and β and aromatase as independent
predictors for prostate cancer outcome. Sci Rep. 6:331142016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dey P, Jonsson P, Hartman J, Williams C,
Ström A and Gustafsson JÅ: Estrogen receptors β1 and β2 have
opposing roles in regulating proliferation and bone metastasis
genes in the prostate cancer cell line PC3. Mol Endocrinol.
26:1991–2003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cunningham JM, Hebbring SJ, McDonnell SK,
Cicek MS, Christensen GB, Wang L, Jacobsen SJ, Cerhan JR, Blute ML,
Schaid DJ and Thibodeau SN: Evaluation of genetic variations in the
androgen and estrogen metabolic pathways as risk factors for
sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers
Prev. 16:969–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nicolaiew N, Cancel-Tassin G, Azzouzi AR,
Le Grand B, Mangin P, Cormier L, Fournier G, Giordanella JP,
Pouchard M, Escary JL, et al: Association between estrogen and
androgen receptor genes and prostate cancer risk. Eur J Endocrinol.
160:101–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Holt SK, Kwon EM, Fu R, Kolb S, Feng Z,
Ostrander EA and Stanford JL: Association of variants in
estrogen-related pathway genes with prostate cancer risk. Prostate.
73:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Robles-Fernandez I, Martinez-Gonzalez LJ,
Pascual-Geler M, Cozar JM, Puche-Sanz I, Serrano MJ, Lorente JA and
Alvarez-Cubero MJ: Association between polymorphisms in sex
hormones synthesis and metabolism and prostate cancer
aggressiveness. PLoS One. 12:e01854472017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tang L, Platek ME, Yao S, Till C, Goodman
PJ, Tangen CM, Wu Y, Platz EA, Neuhouser ML, Stanczyk FZ, et al:
Associations between polymorphisms in genes related to estrogen
metabolism and function and prostate cancer risk: Results from the
prostate cancer prevention trial. Carcinogenesis. 39:125–133. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen YC, Kraft P, Bretsky P, Ketkar S,
Hunter DJ, Albanes D, Altshuler D, Andriole G, Berg CD, Boeing H,
et al: Sequence variants of estrogen receptor beta and risk of
prostate cancer in the national cancer institute breast and
prostate cancer cohort consortium. Cancer Epidemiol Biomarkers
Prev. 16:1973–1981. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chae YK, Huang HY, Strickland P, Hoffman
SC and Helzlsouer K: Genetic polymorphisms of estrogen receptors
alpha and beta and the risk of developing prostate cancer. PLoS
One. 4:e65232009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun T, Lee GS, Werner L, Pomerantz M, Oh
WK, Kantoff PW and Freedman ML: Inherited variations in AR, ESR1,
and ESR2 genes are not associated with prostate cancer
aggressiveness or with efficacy of androgen deprivation therapy.
Cancer Epidemiol Biomarkers Prev. 19:1871–1878. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Safarinejad MR and Safarinejad S, Shafiei
N and Safarinejad S: Estrogen receptors alpha (rs2234693 and
rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism
in prostate cancer: Evidence for association with risk and
histopathological tumor characteristics in Iranian men. Mol
Carcinog. 51:E104–E117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Balistreri CR, Caruso C, Carruba G, Miceli
V and Candore G: Genotyping of sex hormone-related pathways in
benign and malignant human prostate tissues: Data of a preliminary
study. OMICS. 15:369–374. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hoogendoorn B, Coleman SL, Guy CA, Smith
K, Bowen T, Buckland PR and O'Donovan MC: Functional analysis of
human promoter polymorphisms. Hum Mol Genet. 12:2249–2254. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fischer C, Juhasz-Boess I, Lattrich C,
Ortmann O and Treeck O: Estrogen receptor beta gene polymorphisms
and susceptibility to uterine fibroids. Gynecol Endocrinol. 26:4–9.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Treeck O, Elemenler E, Kriener C, Horn F,
Springwald A, Hartmann A and Ortmann O: Polymorphisms in the
promoter region of ESR2 gene and breast cancer susceptibility. J
Steroid Biochem Mol Biol. 114:207–211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen L, Liang Y, Qiu J, Zhang L, Chen X,
Luo X and Jiang J: Significance of rs1271572 in the estrogen
receptor beta gene promoter and its correlation with breast cancer
in a southwestern Chinese population. J Biomed Sci. 20:322013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Thellenberg-Karlsson C, Lindström S,
Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P,
Nilsson M, Dahlman-Wright K, Gustafsson JA and Grönberg H: Estrogen
receptor beta polymorphism is associated with prostate cancer risk.
Clin Cancer Res. 12:1936–1941. 2006. View Article : Google Scholar : PubMed/NCBI
|
